(3Z)-Hex-3-en-1-yl methyl carbonate
Common Name: |
(3Z)-Hex-3-en-1-yl methyl carbonate |
IUPAC Name: |
[(Z)-hex-3-enyl] methyl carbonate |
Molecular Formula: |
C8H14O3 |
SMILES: |
CCC=CCCOC(=O)OC |
Inchi: |
1S/C8H14O3/c1-3-4-5-6-7-11-8(9)10-2/h4-5H,3,6-7H2,1-2H3/b5-4- |
Inchi Key: |
BLOXMGXSDAAJGX-PLNGDYQASA-N |
Cas No: |
67633-96-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
158.19 |
Mass (g/mol) |
158.094 |
Molar Refractivity |
42.86 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
6 |
Rings |
|
TPSA |
35.53 |
Hetero Atoms |
3 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
184.00 to 185.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.721 |
Vapor Density (Air =1) |
>1 |
Fraction Csp3 |
0.62 |
LogP |
2.126 |
iLOGP |
2.79 |
XLOGP3 |
2.29 |
WLOGP |
2.13 |
MLOGP |
1.38 |
ESOL Log S |
-1.87 |
ESOL Solubility (mg/ml) |
2.15 |
ESOL Solubility (mol/l) |
0.014 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.67 |
Ali Solubility (mg/ml) |
0.34 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.38 |
Silicos-IT Solubility (mg/ml) |
6.66 |
Silicos-IT Solubility (mol/l) |
0.04 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.64 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.875 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.507 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |